Old Mission Capital LLC Incannex Healthcare LTD Transaction History

Old Mission Capital LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.72 - $4.76 $55,942 - $97,898	20,567 New	20,567 $57,000
Q2 2022 Aug 05, 2022	SELL	$3.86 - $9.14 $38,600 - $91,400	-10,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$9.16 - $35.5 $91,600 - $355,000	10,000 New	10,000 $92,000

Ticker IXHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 51,693,400
Market Cap $151M
Description
Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's products include IHL-42X, which is in Phase II clinical trials for obstructive sleep apnea; IHL-216A for traumatic brain injury...

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Old Mission Capital LLC with notifications on news.